Washington, United States:
US biotech mainstay Pfizer and its German partner BioNtech on Friday requested permission to rapidly phase out their coronovirus vaccine, a first step towards relief to reduce infection, which earlier this year made a comeback to close countries and the global economy.
The world is watching scientists to free themselves from the global epidemic. The United States Food and Drug Administration (FDA) said the vaccines committee will meet on December 10 to discuss the emergency use authority’s request.
The head of the organization, Stephen Hain, said in a statement: “The FDA believes that transparency and negotiation are essential to have confidence in COVID-19 vaccines.”
“I want to assure the American people that the FDA process and data assessment for the potential COVID-19 vaccine will be as open and transparent as possible.”
He said he couldn’t guess how long the review would take, but the federal government said the final green light would likely be given in December.
Pfizer CEO Albert Borla has taken an important step in our journey to deliver a COVID-19 vaccine to the world.
BioNTech / Pfizer Schott and another being developed by the American company Modern pioneered global research for the vaccine.
European Union Commission President Ursula von der Leyen said the European bloc could approve both before the end of the year.
No miracle solution
But the complex and complex issue of speeding up production and distribution implies that there will be no immediate buyback.
And the latest wave of epidemics is making many areas more difficult to reach around the world than before after the virus first emerged in the Chinese city of Wuhan late last year.
Global deaths are approaching 1.4 million and infections close to 57 million – although the exact number is unknown as countries have different reporting methods and many cases are predictable.
The infection in India is over nine million – just behind the United States – and some of its cemeteries are running out of space.
“When the virus first broke (at the time), I thought I would bury 100 to 200 people and it would be done. But the current situation is beyond my best thoughts, ”New Delhi-based Mohammed Shamim told AFP.
And Mexico became the fourth country to see the number of 100,000 people with his death.
“We are at a point where we do not see a clear phase of descent,” Malaquius Lopez, former head of the Mexican health ministry, told AFP.
School in New York
In the United States, President Donald Trump’s eldest son Don Jr. tested positive for the virus earlier this week and claimed to be “in his cabin” without any symptoms.
Trump Jr. is the latest in a long string of infections involving the White House, including his father. The two Trumps have steadily reduced the risk of a pandemic even as cases rise across the country.
More than a million deaths have been reported in the United States since the start of the epidemic, with 1,800 recorded on Friday.
The current figures have alarmed authorities enough to advise people to stay home for the Thanksgiving holiday next week, when Americans typically travel for family reunions.
Not everyone is happy with the new guidelines and regulations – like the 13,000 petitioners who called New York’s decision to close schools but open bars and gyms “meaningless.”
California will also impose curfews from 10:00 a.m. to 5:00 p.m. Saturday – a measure that reflects the fact that Istanbul will begin Friday night for its 15 million people.
Elsewhere, Toronto, Canada’s largest city, will be placed under a new lockdown starting Monday.
And the latest sanctions in Europe include Northern Ireland’s decision to shut down pubs and shops for two more weeks, with Portugal extending the state of emergency until December 8.
But health officials in France said the three-week ban helped them reach the peak of their second wave.
Governments are now feeding their hopes for a vaccine that can save them from business and school closings and stay-at-home orders that put people’s mental health under severe stress.
Spain expects to vaccinate “a very large part” of its 47 million people by mid-2020, while the Netherlands is targeting 3.5 million in the first quarter.
The UK government has said it has asked its independent drug regulator to study Pfizer / BioNotech’s coronavirus vaccine for imminent deployment.
A separate vaccine candidate under development by the University of Oxford and AstraZeneca is currently in phase 3 trials.
But developing countries will face serious challenges. The World Health Organization has called on G20 countries to help close a $ 4.5 billion funding gap for a vaccine distribution program around the world, according to a letter seen by AFP.
And the unprecedented speed at which vaccines are being developed has sounded the alarm bells.
Chinese Sinopharm revealed on Friday that it had already given its experimental vaccine to around one million people.
But top US infectious disease official Anthony Fauci has sought to address concerns about the Pfizer and Modern candidates, saying the speed at which they were “not compromised by safety” is “inadequate with these types of. vaccines ”. Was the reflection of extraordinary scientific progress ”. “
(Except for the title, this story was not edited by NDTV staff and posted from a syndicated feed.)